Department of Biochemistry, School of Life Sciences, University of Hyderabadgrid.18048.35, Hyderabad, India.
Department of Biotechnology and Bioinformatics, School of Life Sciences, University of Hyderabadgrid.18048.35, Hyderabad, India.
mSphere. 2021 Dec 22;6(6):e0071821. doi: 10.1128/mSphere.00718-21. Epub 2021 Nov 3.
The homologous recombination (HR) pathway has been implicated as the predominant mechanism for the repair of chromosomal DNA double-strand breaks (DSBs) of the malarial parasite. Although the extrachromosomal mitochondrial genome of this parasite experiences a greater number of DSBs due to its close proximity to the electron transport chain, nothing is known about the proteins involved in the repair of the mitochondrial genome. We investigated the involvement of nucleus-encoded HR proteins in the repair of the mitochondrial genome, as this genome does not code for any DNA repair proteins. Here, we provide evidence that the nucleus-encoded "recombinosome" of the parasite is also involved in mitochondrial genome repair. First, two crucial HR proteins, namely, Plasmodium falciparum Rad51 (PfRad51) and P. falciparum Bloom helicase (PfBlm) are located in the mitochondria. They are recruited to the mitochondrial genome at the schizont stage, a stage that is prone to DSBs due to exposure to various endogenous and physiologic DNA-damaging agents. Second, the recruitment of these two proteins to the damaged mitochondrial genome coincides with the DNA repair kinetics. Moreover, both the proteins exit the mitochondrial DNA (mtDNA) once the genome is repaired. Most importantly, the specific chemical inhibitors of PfRad51 and PfBlm block the repair of UV-induced DSBs of the mitochondrial genome. Additionally, overexpression of these two proteins resulted in a kinetically faster repair. Given the essentiality of the mitochondrial genome, blocking its repair by inhibiting the HR pathway could offer a novel strategy for curbing malaria. The impact of malaria on global public health and the world economy continues to surge despite decades of vaccine research and drug development efforts. An alarming rise in resistance toward all the commercially available antimalarial drugs and the lack of an effective malaria vaccine brings us to the urge to identify novel intervention strategies for curbing malaria. Here, we uncover the molecular mechanism behind the repair of the most deleterious form of DNA lesions on the parasitic mitochondrial genome. Given that the single-copy mitochondrion is an indispensable organelle of the malaria parasite, we propose that targeting the mitochondrial DNA repair pathways should be exploited as a potential malaria control strategy. The establishment of the parasitic homologous recombination machinery as the predominant repair mechanism of the mitochondrial DNA double-strand breaks underscores the importance of this pathway as a novel druggable target.
同源重组 (HR) 途径已被认为是修复疟原虫染色体 DNA 双链断裂 (DSB) 的主要机制。尽管这种寄生虫的染色体外线粒体基因组由于靠近电子传递链而经历了更多的 DSB,但对于参与修复线粒体基因组的蛋白质却知之甚少。我们研究了核编码 HR 蛋白在修复线粒体基因组中的作用,因为该基因组不编码任何 DNA 修复蛋白。在这里,我们提供的证据表明,寄生虫的核编码“重组体”也参与了线粒体基因组的修复。首先,两种关键的 HR 蛋白,即疟原虫 Rad51(PfRad51)和疟原虫 Bloom 解旋酶(PfBlm)位于线粒体中。它们在裂殖体阶段被招募到线粒体基因组,裂殖体阶段由于暴露于各种内源性和生理性 DNA 损伤剂而容易发生 DSB。其次,这两种蛋白在受损的线粒体基因组上的募集与 DNA 修复动力学相吻合。此外,一旦基因组被修复,这两种蛋白就会从线粒体 DNA(mtDNA)中退出。最重要的是,PfRad51 和 PfBlm 的特异性化学抑制剂阻断了线粒体基因组中 UV 诱导的 DSB 的修复。此外,这两种蛋白的过表达导致修复动力学更快。鉴于线粒体基因组的重要性,通过抑制 HR 途径来阻断其修复可能为控制疟疾提供一种新策略。尽管几十年来一直在进行疫苗研究和药物开发工作,但疟疾对全球公共卫生和世界经济的影响仍在继续飙升。所有市售抗疟药物的耐药性令人震惊地上升,以及缺乏有效的疟疾疫苗,促使我们迫切需要确定控制疟疾的新干预策略。在这里,我们揭示了修复寄生虫线粒体基因组上最具危害性的 DNA 损伤形式的分子机制。鉴于单拷贝线粒体是疟原虫不可缺少的细胞器,我们提出靶向线粒体 DNA 修复途径应作为一种潜在的疟疾控制策略加以利用。寄生虫同源重组机制作为线粒体 DNA 双链断裂的主要修复机制的确立,凸显了该途径作为一种新的可用药靶的重要性。